State Street's passive stake is consistent with its role as an index fund manager and does not signal activist intent. Monitor for any future 13D conversion or material changes in position size in subsequent filings.
SLS drugs
SLS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $8.37entry
- T+1 · 6d ago +0.60%α −0.72% · $8.42
- T+5 · due 10h ago Pending
- T+5 · todayOpen
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
State Street Corp filed a Schedule 13G disclosing a 5.1% passive beneficial ownership stake in SELLAS Life Sciences Group as of September 30, 2026, representing 10,373,074 shares. This is an amendment to a prior 13G filing from August 2026, indicating a continued passive position with no intent to influence control.
Key Financial Metrics
Key Facts
- State Street Corp disclosed a 5.1% passive beneficial ownership stake in SELLAS Life Sciences Group
- Stake consists of 10,373,074 shares of common stock as of September 30, 2026
- Filing is an amendment to a prior Schedule 13G filed on August 7, 2026
- State Street certifies the securities were acquired and held in the ordinary course of business with no intent to influence control
- State Street is a bank holding company filing under Rule 13d-1(b)
Financial Impact
5.1% passive stake valued at approximately $86.7 million based on market cap of $1.7B
Risk Factors
- No material risks identified from this routine passive stake filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000093751-26-000723 |
| Document: 0000093751-26-000723-index.html | 0000093751-26-000723 |
| Document: 0000093751-26-000723.txt | 0000093751-26-000723 |
Track record
16 reports on SLS
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 17, 2026today 424B5 Bearish 6/10 Entry $16.40 Now $19.15 −16.74% settles Feb 17
- Nov 17, 2026today Press Release Bearish 6/10 Entry $18.59 Now $19.15 −3.01% settles Feb 17
- Nov 17, 2026today 8-K Bullish 7/10 Entry $7.75 Now $19.15 +147.10% settles Feb 16
- Nov 17, 2026today Press Release Bullish 8/10 Entry $7.75 Now $19.15 +147.10% settles Feb 16
- Nov 12, 20265d ago 8-K Neutral 5/10 Entry $7.86 Now $19.15 +143.64% settles Feb 11
- Nov 10, 20267d ago SC 13G Neutral 3/10 Viewing Entry $8.37 Now $19.15 +128.79% settles Feb 8
- Nov 3, 202614d ago Institutional Cluster Neutral 3/10 Entry $8.87 Now $19.15 +115.90% settles Feb 1
- Oct 28, 202620d ago Press Release Mixed 7/10 Entry $10.38 Now $19.15 +84.49% settles Jan 26
- Oct 27, 202621d ago SC 13G/A Neutral 3/10 Entry $10.38 Now $19.15 +84.49% settles Jan 26
- Sep 25, 20267w ago Press Release Neutral 3/10 Entry $11.61 Now $19.15 +64.94% settles Dec 21
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers